Original paper
Who would benefit from average value‐based pricing?
Abstract
There has been debate over the appropriate basis by which decisions relating to the adoption of health technologies should be made in the presence of heterogeneity in outcomes across patients. Stratified cost-effectiveness analysis (SCEA) was originally proposed as a method of determining the optimal patient subgroups or strata for which treatments should be reimbursed (Coyle, Buxton, & O'Brien, 2003). SCEA is based on the recognition that, in...
Paper Details
Title
Who would benefit from average value‐based pricing?
Published Date
Jun 24, 2020
Journal
Volume
29
Issue
8
Pages
936 - 937
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History